20 April 2004
Interferon monotherapy in CCPD patient with chronic hepatitis C: case report
Joanna Konopa, Monika Lichodziejewska-Niemierko, Zofia Michalska, Tomasz Liberek, Bolesław RutkowskiCase Rep Clin Pract Rev 2004; 5(null):209-212 :: ID: 12314
Abstract
Background: Hepatitis C virus (HCV) infection is a serious problem for dialysis patients. Chronic liver disease with symptoms of active hepatitis is a contraindication for renal transplantation as the
disease may progress after transplantation. In addition, treatment of HCV infection after kidney transplantation may increase the risk of graft rejection. Therefore, it is necessary to consider an effective antiviral therapy before transplantation. Optimal dose and time of treatment of peritoneal dialysis patients has not been established.Case Report: 35-year-old woman with chronic renal failure has been treated by continuous cyclic peritoneal dialysis (CCPD). She was planned to be put on the waiting list for renal transplantation. Due to HCV infection interferon-?2a was given as monotherapy at a dose of 6 million units (MU) thrice weekly subcutaneously for five months. After this time reduction of dosage was required because of side effects. Interferon-?2b was administrated as a continuation of therapy at a dose of 3 MU thrice weekly for five consecutive months. The patient became HCV-RNA-PCR negative within 10 months from starting therapy. Fourteen months after cessation of interferon therapy she has still undetectable serum HCV-RNA.Conclusions: This case report documents that administration of IFN-? at 6 MU three times a week for 5 months followed by reduced dose to 50 % for the same time in CCPD patient with hepatitis C was efficient for clearing the serum of HCV-RNA. However, the optimal dose and duration of interferon monotherapy in CCPD patients need to be studied further in a clinical trial on a larger population of patients.
Keywords: HCV infection, Peritoneal Dialysis, Interferon-alpha, Interferon-α
28
In Press
06 Mar 2024 : Case report
Successful Healing of Periapical Pathology with Partial Pulpotomy in a Mature Permanent Molar: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942937
12 Mar 2024 : Case report
Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeu...Am J Case Rep In Press; DOI: 10.12659/AJCR.943244
13 Mar 2024 : Case report
Recurrent Marginal Zone Lymphoma with Bone Marrow Involvement Detected by ¹⁸F-FDG PET/CT and Biopsy: A Diag...Am J Case Rep In Press; DOI: 10.12659/AJCR.943275
13 Mar 2024 : Case report
Unveiling the Temporal Aspect of MRI Tattoo Reactions: A Prospective Evaluation of a Newly-Acquired Tattoo ...Am J Case Rep In Press; DOI: 10.12659/AJCR.943411
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250